Cargando…

Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset

BACKGROUND: Recent Alzheimer's disease (AD) research has focused on finding biomarkers to identify disease at the pre-clinical stage of mild cognitive impairment (MCI), allowing treatment to be initiated before irreversible damage occurs. Many studies have examined brain imaging or cerebrospina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnstone, Daniel, Milward, Elizabeth A., Berretta, Regina, Moscato, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317783/ https://www.ncbi.nlm.nih.gov/pubmed/22485168 http://dx.doi.org/10.1371/journal.pone.0034341

Ejemplares similares

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
por: Gamberger, Dragan, et al.
Publicado: (2016)

Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
por: Huckvale, Erik D., et al.
Publicado: (2021)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
por: Vasanthakumar, Aparna, et al.
Publicado: (2020)

Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer’s Disease Progression
por: Arefin, Ahmed Shamsul, et al.
Publicado: (2012)

Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer’s disease in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Fan, Lei, et al.
Publicado: (2023)

Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer’s Disease Neuroimaging (ADNI) database
por: Beltrán, Juan Felipe, et al.
Publicado: (2020)

How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database
por: Dimitriadis, Stavros I., et al.
Publicado: (2018)

Alzheimer’s disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset
por: Tishchenko, Inna, et al.
Publicado: (2016)

Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
por: Akamatsu, Go, et al.
Publicado: (2019)

Identification of Differentially Expressed Genes through Integrated Study of Alzheimer’s Disease Affected Brain Regions
por: Puthiyedth, Nisha, et al.
Publicado: (2016)

Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease
por: Gómez Ravetti, Martín, et al.
Publicado: (2010)

Differences in Abundances of Cell-Signalling Proteins in Blood Reveal Novel Biomarkers for Early Detection Of Clinical Alzheimer's Disease
por: Rocha de Paula, Mateus, et al.
Publicado: (2011)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

An Alzheimer’s disease category progression sub-grouping analysis using manifold learning on ADNI
por: van der Haar, Dustin, et al.
Publicado: (2023)

Identification of a 5-Protein Biomarker Molecular Signature for Predicting Alzheimer's Disease
por: Gómez Ravetti, Martín, et al.
Publicado: (2008)

Q & A: The Alzheimer's disease neuroimaging initiative
por: Aisen, Paul S
Publicado: (2011)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging
por: Fujishima, Motonobu, et al.
Publicado: (2017)

The neural signatures of psychoses in Alzheimer’s disease: a neuroimaging genetics approach
por: Manca, Riccardo, et al.
Publicado: (2022)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
por: Canevelli, Marco, et al.
Publicado: (2020)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
por: O'Bryant, Sid E., et al.
Publicado: (2011)

Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer’s disease: a study of ADNI cohorts
por: Song, Ailin, et al.
Publicado: (2016)

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB
por: Jamalian, Samira, et al.
Publicado: (2023)

Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam‐era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD‐ADNI) study
por: Clark, Alexandra L., et al.
Publicado: (2021)

Neuroimaging Measures as Endophenotypes in Alzheimer's Disease
por: Braskie, Meredith N., et al.
Publicado: (2011)

Neuroimaging of Mouse Models of Alzheimer’s Disease
por: Jullienne, Amandine, et al.
Publicado: (2022)

Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI
por: Delor, I, et al.
Publicado: (2013)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Retinal pathological features and proteome signatures of Alzheimer’s disease
por: Koronyo, Yosef, et al.
Publicado: (2023)

Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
por: Roberts, Jackson A., et al.
Publicado: (2023)

Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
por: Falgàs, Neus, et al.
Publicado: (2020)

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
por: Barnes, Josephine, et al.
Publicado: (2013)

A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study
por: Puthiyedth, Nisha, et al.
Publicado: (2015)

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
por: Fleisher, Adam S., et al.
Publicado: (2009)

Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease
por: Wollman, Daniel E., et al.
Publicado: (2003)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4c87rl511drhl7iqdt2ug7nkd